Zoetis (ZTS) Non-Current Assets (2012 - 2026)
Zoetis' (ZTS) quarterly Non-Current Assets came in at $8.7 billion in Q2 2026, up 1.93% year-over-year from $8.6 billion in Q2 2025, and little changed quarter-over-quarter from $8.7 billion in Q1 2026.
Analysis
Zoetis (ZTS) Non-Current Assets (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Non-Current Assets for 15 consecutive years, with $8.7 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non-Current Assets rose 1.93% year-over-year to $8.7 billion in Q2 2026; TTM through Jun 2026 was $34.7 billion, a 4.81% increase from a year earlier, with the FY2025 full-year figure at $8.7 billion, up 5.65% from the prior year.
- Non-Current Assets was $8.7 billion for Q2 2026 at Zoetis, roughly flat from $8.7 billion in the prior quarter.
- Over five years, Non-Current Assets peaked at $8.7 billion in Q2 2026 and troughed at $7.0 billion in Q1 2022.
- A 5-year average of $8.0 billion and a median of $8.0 billion in 2024 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets gained 0.3% in 2022 and advanced 10.68% in 2023, its largest moves.
- Over 5 years, Non-Current Assets stood at $7.4 billion in 2022, then rose by 7.25% to $8.0 billion in 2023, then gained by 3.69% to $8.3 billion in 2024, then grew by 5.65% to $8.7 billion in 2025, then rose by 0.05% to $8.7 billion in 2026.
- The last three Non-Current Assets figures came in at $8.7 billion (Q2 2026), $8.7 billion (Q1 2026), and $8.7 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.69 Bn | 40.49 Bn | 779.09 Mn | 1.93 Bn |
| 2 | Zoetis | 30.63 Bn | 28.95 Bn | 1.05 Bn | 8.72 Bn |
| 3 | Elanco Animal Health | 11.77 Bn | 11.24 Bn | 798.00 Mn | 9.76 Bn |
| 4 | Phibro Animal Health | 1.49 Bn | 1.41 Bn | 134.40 Mn | 565.74 Mn |
| 5 | Immucell | 90.19 Mn | 81.33 Mn | 2.44 Mn | 25.55 Mn |
| 6 | Zhengye Biotechnology Holding | 76.23 Mn | 69.14 Mn | - | 42.16 Mn |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | 268,652.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.72 Bn |
| Mar 31, 2026 | 8.68 Bn |
| Dec 31, 2025 | 8.72 Bn |
| Sep 30, 2025 | 8.58 Bn |
| Jun 30, 2025 | 8.56 Bn |
| Mar 31, 2025 | 8.22 Bn |
| Dec 31, 2024 | 8.25 Bn |
| Sep 30, 2024 | 8.08 Bn |
| Jun 30, 2024 | 7.96 Bn |
| Mar 31, 2024 | 7.99 Bn |
| Dec 31, 2023 | 7.96 Bn |
| Sep 30, 2023 | 7.88 Bn |
| Jun 30, 2023 | 7.57 Bn |
| Mar 31, 2023 | 7.49 Bn |
| Dec 31, 2022 | 7.42 Bn |
| Sep 30, 2022 | 7.12 Bn |
| Jun 30, 2022 | 7.12 Bn |
| Mar 31, 2022 | 7.02 Bn |
| Dec 31, 2021 | 6.97 Bn |
| Sep 30, 2021 | 7.02 Bn |